Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis

This publication has 32 references indexed in Scilit:

• Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
  Blood, 2008
• The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
  Journal of Cellular and Molecular Medicine, 2008
• The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
  Cellular and Molecular Life Sciences, 2007
• FOXP3 ensembles in T‐cell regulation
  Immunological Reviews, 2006
• Rationale for the Use of Histone Deacetylase Inhibitors as a Dual Therapeutic Modality in Multiple Sclerosis
  Epigenetics, 2006
• Resetting the Epigenetic Histone Code in the MRL-lpr/lpr Mouse Model of Lupus by Histone Deacetylase Inhibition
  Journal of Proteome Research, 2005
• Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107
  Proceedings of the National Academy of Sciences, 2005
• The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+T cells
  Arthritis Research & Therapy, 2005
• A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis
  Molecular Therapy, 2003
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
  Nature Immunology, 2003